11-5857589-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001005168.3(OR52E8):ā€‹c.102C>Gā€‹(p.Phe34Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 31)
Exomes š‘“: 0.00011 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

OR52E8
NM_001005168.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.37
Variant links:
Genes affected
OR52E8 (HGNC:15217): (olfactory receptor family 52 subfamily E member 8) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
TRIM5 (HGNC:16276): (tripartite motif containing 5) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein forms homo-oligomers via the coilel-coil region and localizes to cytoplasmic bodies. It appears to function as a E3 ubiquitin-ligase and ubiqutinates itself to regulate its subcellular localization. It may play a role in retroviral restriction. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.114280164).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OR52E8NM_001005168.3 linkuse as main transcriptc.102C>G p.Phe34Leu missense_variant 1/1 ENST00000537935.2 NP_001005168.2 Q6IFG1A0A126GVH0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OR52E8ENST00000537935.2 linkuse as main transcriptc.102C>G p.Phe34Leu missense_variant 1/16 NM_001005168.3 ENSP00000444054.2 Q6IFG1
TRIM5ENST00000412903.1 linkuse as main transcriptc.-62+79812C>G intron_variant 1 ENSP00000388031.1 E7EQQ5
TRIM5ENST00000380027.5 linkuse as main transcriptc.-543-1735C>G intron_variant 5 ENSP00000369366.1 Q9C035-4

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000107
AC:
145
AN:
1360576
Hom.:
0
Cov.:
34
AF XY:
0.0000973
AC XY:
66
AN XY:
678092
show subpopulations
Gnomad4 AFR exome
AF:
0.000277
Gnomad4 AMR exome
AF:
0.0000477
Gnomad4 ASJ exome
AF:
0.0000893
Gnomad4 EAS exome
AF:
0.0000905
Gnomad4 SAS exome
AF:
0.0000118
Gnomad4 FIN exome
AF:
0.00201
Gnomad4 NFE exome
AF:
0.0000353
Gnomad4 OTH exome
AF:
0.000130
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 01, 2023The c.114C>G (p.F38L) alteration is located in exon 1 (coding exon 1) of the OR52E8 gene. This alteration results from a C to G substitution at nucleotide position 114, causing the phenylalanine (F) at amino acid position 38 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.6
DANN
Benign
0.87
DEOGEN2
Benign
0.00036
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.020
N
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.20
N
REVEL
Benign
0.051
Sift
Benign
0.068
T
Sift4G
Benign
0.079
T
Polyphen
0.0010
B
Vest4
0.024
MutPred
0.70
Loss of catalytic residue at P36 (P = 0.0974);
MVP
0.061
MPC
0.0026
ClinPred
0.087
T
GERP RS
-1.3
Varity_R
0.043
gMVP
0.067

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-5878819; API